询 单
请 填 写 相 关 信 息
产品信息
产品名称
别名
CAS号
结构式 上传
联系方式
公司
联系人
电话
邮箱
内容
提交
中文版 English
请输入产品名称、CAS式、分子式
2-(N-Methylamino)isobutyric acid | CAS:2566-34-9
2-(N-Methylamino)isobutyric acid
  • 名称:2-(N-甲基氨基)异丁酸 | 2-(N-Methylamino)isobutyric acid
  • CAS号:2566-34-9
  • 别名:N-Methyl-2-amino-isobutyric acid; N-Methyl-2-methylalanine; N-Methyl-alpha-aminoisobutyric acid; alpha-(Methylamino)isobutyric acid
  • 分子式:C5H11NO2
  • 分子量:117.15
  • EINESC号:219-898-2

产品描述

物理化学性质

熔点 272 ºC (sublm) (ethanol )**
沸点 192.5±23.0 ºC (760 Tor
闪点 70.2±22.6 ºC, 计算值*
密度 1.022±0.06 g/cm3 (20 º

安全数据

没有数据没有数据

SDS

来源 SDS样本
没有数据没有数据
产品合成路线
更多

名称 CAS号
更多
文章
同行评议文献
Biocatalytic production of 5-hydroxy-2-adamantanone by P450cam coupled with NADH regeneration.Furuya T, et al. Journal of Molecular Catalysis. B, Enzymatic, 94, 111-118 (2013) Application of shift reagents in the study of disubstituted derivatives of adamantane by NMR spectroscopy.Vodicka L, et al. Collection of Czechoslovak Chemical Communications, 40(1), 293-299 (1975) [The effect of kemantane on T-helpers and T-suppressors].V M Man'ko et al.Zhurnal mikrobiologii, epidemiologii, i immunobiologii, (9)(9), 66-67 (1991-09-01) Effect of adamantanone derivative possessing anti-HIV properties on the redox processes in the cytochrome P-450 system.I E Kovalev et al.Doklady. Biochemistry and biophysics, 378, 210-213 (2001-11-20) [Interspecific differences in kemantan pharmacokinetics].S S Boĭko et al.Eksperimental'naia i klinicheskaia farmakologiia, 57(6), 48-50 (1994-11-01) [Treatment of immunodeficient conditions caused by viral infection with the Soviet immunomodulator kemantan in patients with pulmonary tuberculosis].N V Kossii et al.Problemy tuberkuleza, (6)(6), 23-26 (1991-01-01) An expeditious preparation of E-2-amino-5-hydroxyadamantane and its Z-isomer.Jaroskova L, et al. Tetrahedron Letters, 47(46), 8063-8067 (2006) [Kemantane pharmacokinetics in rats].S S Boĭko et al.Biulleten' eksperimental'noi biologii i meditsiny, 110(11), 501-503 (1990-11-01) [The mitostatic and lymphotoxic action of kemantane and its effect on B-suppressors].V M Man'ko et al.Zhurnal mikrobiologii, epidemiologii, i immunobiologii, (6)(6), 63-65 (1991-06-01) Chemoselective hydrosilylation of hydroxyketones.Marta L Lage et al.Tetrahedron, 69(27-28), 5609-5613 (2013-09-03) [The immunomodulator kemantan in the treatment of patients with exacerbated chronic obstructive bronchitis].E M Rekalova Likars'ka sprava, (4)(4), 73-76 (1992-04-01) [The clinical pharmacokinetics of kemantane].S S Boĭko et al.Farmakologiia i toksikologiia, 54(1), 57-59 (1991-01-01)
备注

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).

名称 CAS号

相关产品

相关资讯

热门标签
询 单
请 填 写 相 关 信 息
产品信息
产品名称
别名
CAS号
结构式 上传
联系方式
公司
联系人
电话
邮箱
内容
提交